In vivo: Reduces atherosclerosis in LDLR−/− and ApoE−/− mice. Reduces VCAM-1 mRNA levels in the lungs of LPS-stimulated mice (150 mg/kg/day). The gene discussed is VCAM1; the disease is atherosclerosis.